<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502877</url>
  </required_header>
  <id_info>
    <org_study_id>HDLSpot1</org_study_id>
    <nct_id>NCT02502877</nct_id>
  </id_info>
  <brief_title>Core Temperature Variations During Midazolam vs Propofol Sedation for Neuraxial Anesthesia</brief_title>
  <official_title>Core Temperature Variations During Midazolam vs Propofol Sedation for Neuraxial Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital da Luz, Portugal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital da Luz, Portugal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is a pilot study aiming to compare the variation in core temperature
      (measured through the non-invasive device Spot-OnTM3MTM) in patients submitted to neuraxial
      anesthesia for orthopedic procedures, during sedation with midazolam vs propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators will select 20 patients scheduled for orthopedic surgery of
      the knee or foot with neuraxial anesthesia (subarachnoid or sequential blocks). Sedation for
      these procedures with midazolam or propofol is daily practice in the investigators'
      department.

      So the patients will be randomized, through the envelope method, in 2 groups with 10 patients
      each: &quot;midazolam group&quot; and &quot;propofol group&quot;.

      In the &quot;midazolam group&quot; the investigators will administer 0,05mg/kg of midazolam, being 2/3
      administered before the neuraxial block and 1/3 after.

      In the &quot;propofol group&quot; the investigators will administer 0,033mg/kg of midazolam before the
      neuraxial block, and immediately after installation of the block the investigators will start
      a propofol target-controlled infusion (TCI) pump (Schnider model) with an effect
      concentration set at 1mcg/mL. This pump will be turned off at the end of the surgery.

      The neuraxial block will be performed inside the operating room and preferentially in lateral
      decubitus. The choice of drug and dosage used for the block will be left to the
      anesthesiologist, to mimetize day-to-day practice. The limit dermatome of sensory block will
      be noted.

      The investigators will administer to every patient: cefazolin 2g iv bolus, ketorolac 30 mg iv
      bolus, pantoprazole 40 mg iv bolus, paracetamol 1g iv perfusion (initiated 30 minutes before
      the end of surgery).

      Central temperature will be monitored with the SpotOnTM3MTM device from entering till leaving
      the operating room, through a sensor placed in the patient's forehead. Room temperature will
      be kept at 17 degrees Celsius (ºC). Patients will be warmed with a underbody forced-air
      blanket (BairHuggerTM3MTM) set at 38ºC and maximal flow, initiated after performing the
      neuraxial block and stopped right before leaving the operating room.

      Data will be analyzed with the Statistical Package for the Social Sciences (SPSS) program.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean temperature</measure>
    <time_frame>From entering the operating room up to cutaneous closure, an expected average of 1 to 1.5 hours</time_frame>
    <description>Comparison between the mean temperature in the two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of sensory block, T1-12/L1-5, assessed by a blunted needle</measure>
    <time_frame>From 5 to 10 minutes after the performance of the neuraxial block</time_frame>
    <description>Top dermatome of sensory block, evaluated with a blunt needle</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Body Temperature Changes</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Midazolam Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In the &quot;midazolam group&quot; the investigators will administer 0,05mg/kg of midazolam, being 2/3 administered before the neuraxial block and 1/3 after.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the &quot;propofol group&quot; the investigators will administer 0,033mg/kg of midazolam before the neuraxial block, and immediately after installation of the block the investigators will start a propofol TCI pump (Schnider model) with an effect concentration set at 1mcg/mL. This pump will be turned off at the end of the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>The investigators will administer 0,05mg/kg of midazolam, being 2/3 administered before the neuraxial block and 1/3 after.</description>
    <arm_group_label>Midazolam Group</arm_group_label>
    <other_name>A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>The investigators will administer 0,033mg/kg of midazolam before the neuraxial block, and immediately after installation of the block the investigators will start a propofol TCI pump (Schnider model) with an effect concentration set at 1mcg/mL. This pump will be turned off at the end of the surgery.</description>
    <arm_group_label>Propofol group</arm_group_label>
    <other_name>B</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard</intervention_name>
    <description>The investigators will administer to every patient: cefazolin 2g iv bolus, ketorolac 30 mg iv bolus, pantoprazole 40 mg iv bolus, paracetamol 1g iv perfusion (initiated 30 minutes before the end of surgery).</description>
    <arm_group_label>Midazolam Group</arm_group_label>
    <arm_group_label>Propofol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SpotOn</intervention_name>
    <description>Central temperature will be monitored with the SpotOnTM3MTM device from entering till leaving the operating room, through a sensor placed in the patient's forehead</description>
    <arm_group_label>Midazolam Group</arm_group_label>
    <arm_group_label>Propofol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for orthopedic surgery of the foot or knee

          -  Indication to neuraxial anesthesia

          -  Surgery duration &gt; 30 minutes

        Exclusion Criteria:

          -  Preference for deep sedation

          -  Preference for no sedation

          -  Kidney failure

          -  Hepatic failure

          -  No signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>João Gouveia, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital da Luz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital da Luz</name>
      <address>
        <city>Lisboa</city>
        <zip>1500-650</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Sun Z, Honar H, Sessler DI, Dalton JE, Yang D, Panjasawatwong K, Deroee AF, Salmasi V, Saager L, Kurz A. Intraoperative core temperature patterns, transfusion requirement, and hospital duration in patients warmed with forced air. Anesthesiology. 2015 Feb;122(2):276-85. doi: 10.1097/ALN.0000000000000551.</citation>
    <PMID>25603202</PMID>
  </reference>
  <reference>
    <citation>Eshraghi Y, Nasr V, Parra-Sanchez I, Van Duren A, Botham M, Santoscoy T, Sessler DI. An evaluation of a zero-heat-flux cutaneous thermometer in cardiac surgical patients. Anesth Analg. 2014 Sep;119(3):543-9. doi: 10.1213/ANE.0000000000000319.</citation>
    <PMID>25045862</PMID>
  </reference>
  <reference>
    <citation>Jeong CW, Ju J, Lee DW, Lee SH, Yoon MH. Lipid-emulsion propofol less attenuates the regulation of body temperature than micro-emulsion propofol or sevoflurane in the elderly. Yonsei Med J. 2012 Jan;53(1):198-203. doi: 10.3349/ymj.2012.53.1.198.</citation>
    <PMID>22187253</PMID>
  </reference>
  <reference>
    <citation>Iden T, Horn EP, Bein B, Böhm R, Beese J, Höcker J. Intraoperative temperature monitoring with zero heat flux technology (3M SpotOn sensor) in comparison with sublingual and nasopharyngeal temperature: An observational study. Eur J Anaesthesiol. 2015 Jun;32(6):387-91. doi: 10.1097/EJA.0000000000000232. Erratum in: Eur J Anaesthesiol. 2015 Oct;32(10):747.</citation>
    <PMID>25693138</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>April 5, 2016</last_update_submitted>
  <last_update_submitted_qc>April 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital da Luz, Portugal</investigator_affiliation>
    <investigator_full_name>João Pedro Gouveia</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Temperature Changes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

